Antiretroviral drug resistance among antiretroviral-naive individuals with HIV infection of unknown duration in Thailand

Clinical Infectious Diseases

Volumn 46, Issue 10, 2008, Pages 1630-1631

  Apisarnthanarak, Anucha ^a   Mundy, Linda M ^b  

^a THAMMASAT UNIVERSITY HOSPITAL   (Thailand)

^b SAINT LOUIS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LAMIVUDINE; NEVIRAPINE; STAVUDINE; ANTIRETROVIRUS AGENT;

CLINICAL ASSESSMENT; DEMOGRAPHY; DISEASE DURATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; LABORATORY DIAGNOSIS; LETTER; PILL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SEXUAL BEHAVIOR; SEXUALITY; TERTIARY HEALTH CARE; THAILAND; TREATMENT FAILURE; ADOLESCENT; ADULT; ANTIVIRAL RESISTANCE; DRUG EFFECT; FEMALE; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; VIROLOGY;

ADOLESCENT; ADULT; ANTI-RETROVIRAL AGENTS; DRUG RESISTANCE, VIRAL; FEMALE; HIV; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; THAILAND;

EID: 43249115629     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/587753     Document Type: Letter

References (7)

1. Little SJ, Holte S, Routy JP, et al. Antiretroviral-drug resistance among patients recently infected with HIV. N Engl J Med 2002; 347: 385-94.
2. Sungkanuparph S, Manosuthi W, Kiertiburanakul S, Piyavong B, Chumpathat N, Chantratita W. Options for a second-line antiretroviral regimen for HIV type 1-infected patients whose initial regimen of a fixed-dose combination of stavudine, lamivudine, and nevirapine fails. Clin Infect Dis 2007; 44:447-52.
3. Sukasem C, Churdboonchart V, Chasombat S, et al. Surveillance of genotypic resistance mutations in chronic HIV-1 treated individuals after completion of the National Access to Antiretroviral Program in Thailand. Infection 2007; 35:81-8.
4. Kuritzkes DR, Grant RM, Feorino P, et al. Performance characteristics of the Trugene HIV-1 genotyping kit and the Opengene DNA sequencing system. J Clin Microbiol 2003; 41: 1594-9.
5. Johnson VA, Brun-Vezinet F, Clotet B, et al. Update of the drug resistance mutations in HIV-1: fall 2005. Top HIV Med 2005; 13: 125-31.
6. Hirsch MS, Brun-Vezinet F, Clotet B, et al. Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel. Clin Infect Dis 2003; 37:113-28.
7. Sax PE, Islam R, Walensky RP, et al. Should resistance testing be performed for treatment-naive HIV-infected patients? A cost-effectiveness analysis. Clin Infect Dis 2005; 41:1316-23.